A new strategy in the war on renal cell cancer: hitting multiple targets with limited collateral damage. [electronic resource]
- JAMA Jun 2006
- 2537-8 p. digital
Publication Type: Editorial; Comment
1538-3598
10.1001/jama.295.21.2537 doi
Antineoplastic Agents--therapeutic use Carcinoma, Renal Cell--drug therapy Humans Indoles--therapeutic use Kidney Neoplasms--drug therapy Protein Kinase Inhibitors--therapeutic use Pyrroles--therapeutic use Sunitinib